Buprenorphine Transdermal System is supplied in cartons containing 4 individually-packaged - systems and a pouch containing 4 Patch-Disposal Units. Buprenorphine Transdermal Systems, 5 mcg/hour, are ... Bupreplast Patch reduces cravings and withdrawal symptoms, making it easier for individuals to stop using opioids. As a partial opioid agonist, it helps stabilize brain function without producing the intense "high" associated with opioid misuse, which lowers the risk of relapse. Find patient medical information for Buprenorphine transdermal (Butrans) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings Common side effects of Buprenorphine transdermal include: constipation, nausea, vomiting, headache, dizziness, drowsiness, tiredness, and redness, itching, or rash where the patch was worn Serious side effects of Buprenorphine transdermal include: weak or shallow breathing, deep sighs, new or unusual snoring, breathing that stops during sleep, chest pain, fast heart rate, seizure, lightheadedness, blisters, swelling, severe irritation at the patch site, nausea, vomiting, loss of appetite ...

Available

Product reviews

Rating 4.5 out of 5. 8,008 reviews.

Characteristics assessment

Cost-benefit

Rating 4.5 out of 10 5

Comfortable

Rating 4.3 out of 5

It's light

Rating 4.3 out of 5

Quality of materials

Rating 4.1 of 5

Easy to assemble

Assessment 4 of 5